Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
Feutren
G
G
Laboratoires Sandoz, Rueil-Malmaison, France.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001794:Blood Pressure; D002648:Child; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D003524:Cyclosporins; D003404:Creatinine